David Dyment
David Dyment
Verified email at cheo.on.ca
Cited by
Cited by
Genetics of multiple sclerosis
DA Dyment, GC Ebers, AD Sadovnick
The Lancet Neurology 3 (2), 104-110, 2004
Genetics of multiple sclerosis
DA Dyment, GC Ebers, AD Sadovnick
The Lancet Neurology 3 (2), 104-110, 2004
Twin concordance and sibling recurrence rates in multiple sclerosis
CJ Willer, DA Dyment, NJ Risch, AD Sadovnick, GC Ebers, ...
Proceedings of the National Academy of Sciences 100 (22), 12877-12882, 2003
Expression of the Multiple Sclerosis-Associated MHC Class II Allele HLA-DRB1*1501 Is Regulated by Vitamin D
SV Ramagopalan, NJ Maugeri, L Handunnetthi, MR Lincoln, SM Orton, ...
PLoS genetics 5 (2), e1000369, 2009
Timing of birth and risk of multiple sclerosis: population based study
CJ Willer, DA Dyment, AD Sadovnick, PM Rothwell, TJ Murray, GC Ebers
Bmj 330 (7483), 120, 2005
Evidence for genetic basis of multiple sclerosis
AD Sadovnick, DA Dyment, GC Ebers, NJ Risch, ...
The Lancet 347 (9017), 1728-1730, 1996
A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis
MR Lincoln, A Montpetit, MZ Cader, J Saarela, DA Dyment, M Tiislar, ...
Nature genetics 37 (10), 1108-1112, 2005
Parent-of-origin effect in multiple sclerosis: observations in half-siblings
GC Ebers, AD Sadovnick, DA Dyment, IML Yee, CJ Willer, N Risch
The Lancet 363 (9423), 1773-1774, 2004
Utility of whole‐exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care
SL Sawyer, T Hartley, DA Dyment, CL Beaulieu, J Schwartzentruber, ...
Clinical genetics 89 (3), 275-284, 2016
Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance
DA Dyment, BM Herrera, MZ Cader, CJ Willer, MR Lincoln, AD Sadovnick, ...
Human molecular genetics 14 (14), 2019-2026, 2005
Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype
SL Sawyer, L Tian, M Kähkönen, J Schwartzentruber, M Kircher, ...
Cancer discovery 5 (2), 135-142, 2015
Rare variants in the CYP27B1 gene are associated with multiple sclerosis
SV Ramagopalan, DA Dyment, MZ Cader, KM Morrison, G Disanto, ...
Annals of neurology 70 (6), 881-886, 2011
FORGE Canada Consortium: outcomes of a 2-year national rare-disease gene-discovery project
CL Beaulieu, J Majewski, J Schwartzentruber, ME Samuels, ...
The American Journal of Human Genetics 94 (6), 809-817, 2014
Genetics of multiple sclerosis
DA Dyment, AD Sadnovich, GC Ebers
Human Molecular Genetics 6 (10), 1693-1698, 1997
The inheritance of resistance alleles in multiple sclerosis
SV Ramagopalan, AP Morris, DA Dyment, BM Herrera, GC DeLuca, ...
PLoS genetics 3 (9), e150, 2007
XRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia
NC Hoch, H Hanzlikova, SL Rulten, M Tétreault, E Komulainen, L Ju, ...
Nature 541 (7635), 87-91, 2017
Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility
MR Lincoln, SV Ramagopalan, MJ Chao, BM Herrera, GC DeLuca, ...
Proceedings of the National Academy of Sciences 106 (18), 7542-7547, 2009
Autoimmune disease in families with multiple sclerosis: a population-based study
SV Ramagopalan, DA Dyment, W Valdar, BM Herrera, M Criscuoli, ...
The Lancet Neurology 6 (7), 604-610, 2007
An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus
GC DeLuca, SV Ramagopalan, BM Herrera, DA Dyment, MR Lincoln, ...
Proceedings of the National Academy of Sciences 104 (52), 20896-20901, 2007
Mutations in PIK3R1 cause SHORT syndrome
DA Dyment, AC Smith, D Alcantara, JA Schwartzentruber, ...
The American Journal of Human Genetics 93 (1), 158-166, 2013
The system can't perform the operation now. Try again later.
Articles 1–20